The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
Open accessAbstract
Patients with cancer experience a host of behavioral alterations that include depression, fatigue, sleep disturbances, and cognitive dysfunction. These behavioral comorbidities are apparent throughout the process of diagnosis and treatment for cancer and can persist well into the survivorship period. There is a rich literature describing potential consequences of behavioral comorbidities in patients with cancer including impaired quality of life, reduced treatment adherence, and increased disease-related morbidity and mortality. Medical complications of cancer and its treatment such as anemia, thyroid dysfunction, and the neurotoxicity of cancer chemotherapeutic agents account in part for these behavioral changes. Nevertheless, recent advances in the neurosciences and immunology/oncology have revealed novel insights into additional pathophysiologic mechanisms that may significantly contribute to the development of cancer-related behavioral changes. Special attention has been focused on immunologic processes, specifically activation of innate immune inflammatory responses and their regulation by neuroendocrine pathways, which, in turn, influence CNS functions including neurotransmitter metabolism, neuropeptide function, sleep-wake cycles, regional brain activity, and, ultimately, behavior. Further understanding of these immunologic influences on the brain provides a novel conceptual framework for integrating the wide spectrum of behavioral alterations that occur in cancer patients and may reveal a more focused array of translational targets for therapeutic interventions and future research. Such developments warrant complementary advances in identification of cancer patients at risk as well as those currently suffering, including an increased emphasis on the status of behavior as a “sixth vital sign” to be assessed in all cancer patients throughout their disease encounter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the physical and psychological stressors of breast cancer diagnosis and treatment may activate inflammatory pathways, leading to elevated inflammation in survivors [46, 47]”
From Moderators of inflammation-related depression: a prospective study of breast cancer survivors (2021) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120 · cited 1×
“Functional polymorphisms in the IL-6 gene and the serotonin transporter gene may be especially relevant, given the association of IL-6 with several behavioral pathologies in cancer patients and the demonstrated role of serotonin transporter polymorphisms in the relationship between stress and behavior alterations.(111…”
BackgroundImpact of sleep debt on metabolic and endocrine function
Spiegel, K., Leproult, R., & Van Cauter, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01376-8 · Cited by 3,668
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Self-citationCausal Relationship Between Stressful Life Events and the Onset of Major Depression
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.837 · Cited by 2,566
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513 · cited 1×
“Moreover, in the case of hsCRP, cutoff values have been established that have both predictive validity and categorization of risk in relation to disease outcome in cardiovascular disorders.(115) Given the fluctuating status of cancer patients during treatment, it is also suggested that longitudinal assessments of both…”
BackgroundRidker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243 · cited 1×
“Functional polymorphisms in the IL-6 gene and the serotonin transporter gene may be especially relevant, given the association of IL-6 with several behavioral pathologies in cancer patients and the demonstrated role of serotonin transporter polymorphisms in the relationship between stress and behavior alterations.(111…”
Background
Cited by
Cancer-related fatigue—mechanisms, risk factors, and treatments
Bower, J. E. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.127 · Cited by 1,666
Self-citationBreast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Cancer-Related Fatigue, Version 2.2015
Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., Cleeland, C., Dotan, E., Eisenberger, M. A., Escalante, C. P., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0122 · Cited by 949
Reciprocal regulation of the neural and innate immune systems
Irwin, M. R., & Cole, S. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3042 · Cited by 910
“, and documented increased rates of MDD in clinical conditions involving high levels of inflammation (for example, in patients with cancer”
BackgroundSelf-citationCytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652
Psychologic intervention improves survival for breast cancer patients: A randomized clinical trial
Andersen, B. L., Yang, H., Farrar, W. B., Golden‐Kreutz, D. M., Emery, C. F., Thornton, L. M., Young, D. C., & Carson, W. E. (2008) · Cancer · doi:10.1002/cncr.23969 · Cited by 493
Bower, J. E., Ganz, P. A., Irwin, M. R., Kwan, L., Breen, E. C., & Cole, S. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1154 · Cited by 486
Self-citationInflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
Mindfulness meditation for younger breast cancer survivors: A randomized controlled trial
Bower, J. E., Crosswell, A. D., Stanton, A. L., Crespi, C. M., Winston, D., Arevalo, J., Ma, J., Cole, S. W., & Ganz, P. A. (2015) · Cancer · doi:10.1002/cncr.29194 · Cited by 390
Self-citationFelger, J. C., & Miller, A. H. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.003 · Cited by 391
Self-citationBower, J. E., & Lamkin, D. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.011 · Cited by 372
Self-citationYennurajalingam, S., Frisbee-Hume, S., Palmer, J. L., Delgado-Guay, M. O., Bull, J., Phan, A. T., Tannir, N. M., Litton, J. K., Reddy, A., Hui, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.4661 · Cited by 348
The neuroimmune basis of fatigue
Dantzer, R., Heijnen, C. J., Kavelaars, A., Laye, S., & Capuron, L. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.10.003 · Cited by 346
Self-citationCancer, Physical Activity, and Exercise
Brown, J. C., Winters‐Stone, K., Lee, A., & Schmitz, K. H. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c120005 · Cited by 346
Ballesta, A., Innominato, P. F., Dallmann, R., Rand, D. A., & Lévi, F. A. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013441 · Cited by 339
Diurnal cortisol rhythm as a predictor of lung cancer survival
Sephton, S. E., Lush, E., Dedert, E. A., Floyd, A. R., Rebholz, W. N., Dhabhar, F. S., Spiegel, D., & Salmon, P. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.019 · Cited by 309
Bower, J. E., Greendale, G., Crosswell, A. D., Garet, D., Sternlieb, B., Ganz, P. A., Irwin, M. R., Olmstead, R., Arevalo, J., & Cole, S. W. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.019 · Cited by 283
Self-citationBerger, A. M., Abernethy, A. P., Atkinson, A., Barsevick, A. M., Breitbart, W. S., Cella, D., Cimprich, B., Cleeland, C., Eisenberger, M. A., Escalante, C. P., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0067 · Cited by 280
Psychological Prehabilitation Before Cancer Surgery: A Systematic Review
Tsimopoulou, I., Pasquali, S., Howard, R., Desai, A., Gourevitch, D., Tolosa, I., & Vohra, R. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4550-z · Cited by 264
Cognitive-Behavioral Stress Management Reverses Anxiety-Related Leukocyte Transcriptional Dynamics
Antoni, M. H., Lutgendorf, S. K., Blomberg, B., Carver, C. S., Lechner, S., Diaz, A., Stagl, J., Arevalo, J. M. G., & Cole, S. W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.007 · Cited by 251
Evidence‐based treatment of depression in patients with cancer
Li, M., Fitzgerald, P., & Rodin, G. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7372 · Cited by 236
Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
A critical review of human endotoxin administration as an experimental paradigm of depression.
DellaGioia, N., & Hannestad, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.014 · Cited by 175
“various ‘‘medical’’ illnesses is also associated with elevated blood levels of inflammatory markers (Elenkov, 2007; Irwin and Miller, 2007; Miller et al., 2008).”
BackgroundInfluentialSleep disturbance, inflammation and depression risk in cancer survivors
Irwin, M. R., Olmstead, R. E., Ganz, P. A., & Haque, R. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.002 · Cited by 173
Self-citationCancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study
Goldstein, D., Bennett, B. K., Webber, K., Boyle, F., de Souza, P. L., Wilcken, N. R. C., Scott, E. M., Toppler, R., Murie, P., O'Malley, L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.6148 · Cited by 140
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
Rogers, L. Q., Courneya, K. S., Anton, P. M., Verhulst, S., Vicari, S. K., Robbs, R. S., & McAuley, E. (2017) · Psycho-Oncology · doi:10.1002/pon.4254 · Cited by 108
Nakamura, Y., Lipschitz, D. L., Kuhn, R., Kinney, A. Y., & Donaldson, G. W. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-012-0252-8 · Cited by 102
The relationship between depression and physical symptom burden in advanced cancer
Fitzgerald, P., Lo, C., Li, M., Gagliese, L., Zimmermann, C., & Rodin, G. (2015) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2012-000380 · Cited by 101
Stress and coping in women with breast cancer:unravelling the mechanisms to improve resilience
Borgi, M., Collacchi, B., Ortona, E., & Cirulli, F. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.011 · Cited by 90
Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes
Lasselin, J., Layé, S., Dexpert, S., Aubert, A., Gonzalez, C., Gin, H., & Capuron, L. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.03.003 · Cited by 77
Self-citationWagner, L. I., Spiegel, D., & Pearman, T. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0028 · Cited by 79
Daniel, L., Kazak, A. E., Li, Y., Hobbie, W., Ginsberg, J., Butler, E., & Schwartz, L. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-015-2798-2 · Cited by 77
Barrera, I., & Spiegel, D. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864259 · Cited by 75
Circadian disruption and cancer- and treatment-related symptoms
Amidi, A., & Wu, L. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1009064 · Cited by 59
Cognitive-behavioral therapy for children with comorbid physical illness
Thompson, R. D., Delaney, P., Flores, I., & Szigethy, E. (2011) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2011.01.013 · Cited by 57
Minding the body: Psychotherapy and cancer survival
Spiegel, D. (2014) · British Journal of Health Psychology · doi:10.1111/bjhp.12061 · Cited by 53
Dooley, L. N., Ganz, P. A., Cole, S. W., Crespi, C. M., & Bower, J. E. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.059 · Cited by 50
Self-citationCancer and post-traumatic stress disorder: Diagnosis, pathogenesis and treatment considerations
Rustad, J. K., David, D., & Currier, M. B. (2012) · Palliative and Supportive Care · doi:10.1017/s1478951511000897 · Cited by 48
Zetzl, T., Renner, A., Pittig, A., Jentschke, E., Roch, C., & van Oorschot, B. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-020-05794-2 · Cited by 47
Reis, J. C., Antoni, M. H., & Travado, L. (2020) · CNS Spectrums · doi:10.1017/s1092852918001621 · Cited by 44
Nervous system regulation of the cancer genome
Cole, S. W. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.11.008 · Cited by 41
Role of natural products in breast cancer related symptomology: Targeting chronic inflammation
Andrijauskaite, K., & Wargovich, M. J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.011 · Cited by 38
Depression and anxiety in supportive oncology
Li, M., Boquiren, V., Lo, C., & Rodin, G. (2011) · Supportive Oncology · doi:10.1016/b978-1-4377-1015-1.00052-7 · Cited by 32
Li, H., Jin, X., Ng, M. S. N., Mann, K. F., Wang, N., & Wong, C. L. (2022) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2022.100102 · Cited by 29
“Patients meeting the following inclusion criteria were invited to participate in this study: (1) aged 18 years or older; (2) diagnosed with stage III/IV lung cancer through pathological section or cytology; (3) had experienced unexplained fatigue syndrome, with a score of 3 or higher in the Fatigue Symptom Inventory (…”
BackgroundMethodAn, J., Zhou, K., Li, M., & Li, X. (2022) · BMC Women's Health · doi:10.1186/s12905-022-01635-y · Cited by 29
“As the possible mechanism involved, failing to adapt to altered body image may have resulted in psychological distress and chronic stress, which were shown in research to cause cancer patients’ fatigue, impaired sleep, and cognitive dysfunction by affecting the neuroendocrine system and inducing inflammation [32].”
BackgroundModerators of inflammation-related depression: a prospective study of breast cancer survivors
Manigault, A. W., Ganz, P. A., Irwin, M. R., Cole, S. W., Kuhlman, K. R., & Bower, J. E. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01744-6 · Cited by 29
Self-citationSleep Disturbances in Patients with Medical Conditions
Kamath, J., Prpich, G., & Jillani, S. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.07.011 · Cited by 21
Czamanski-Cohen, J., Wiley, J., & Weihs, K. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037521 · Cited by 19
Clara, M. I., Canavarro, M. C., Severina, A., Ramos, S., Rafael, C., & Gomes, A. A. (2024) · Psycho-Oncologie · doi:10.32604/po.2023.044320 · Cited by 3
Metadata
- Authors
- Miller, A. H., Ancoli-Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-02-20
- Volume
- 26
- Issue
- 6
- Pages
- 971-982
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2164859678
- Cited by
- 608
- References
- 158
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.